Statistics for Beam Therapeutics (id:7563 BEAM)

Valuation metrics

Market cap

2.07B

Enterprise value

1.11B

Trailing P/E (ttm)

-14.56

Forward P/E

-5.25

PEG ratio

-5.25

Price/Sales (ttm)

5.93

Price/Book (mrq)

2.51

Enterprise Value/Revenue

3.18

Enterprise Value/EBITDA

-6.92

Overview

Shares outstanding

82.81M

Float

64.81M

Shares short

12.31M

% Held by insiders

0.01%

% Held by institutions

0.93%

Average volume (10 days)

1.30M

Average volume (90 days)

Price summary

52-Week low

20.84

52-Week high

49.50

52-Week change

-16.41%

Beta

1.86

50-Day moving average

24.54

200-Day moving average

26.76

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-41.07%

Operating margin

-746.40%

Operational effectiveness

Return on assets

-9.28%

Return on equity

-18.29%

Income statement

Revenue (ttm)

4.27

Revenue per share (ttm)

4.27

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-160,828,992.00

Net income to common (ttm)

-143,591,008.00

Diluted EPS (ttm)

-1.58

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

925.76M

Total cash per share (mrq)

11.63

Total debt (mrq)

162.06M

Total Debt/Equity (mrq)

20.48

Current ratio (mrq)

568.80%

Book value per share (mrq)

9.97

Cash flow

Cash flow statement

-135,808,000.00

Levered free cash flow (LFCF)

-38,545,624.00